Related Experiment Videos
Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus.
1Department of Ophthalmology, Kobe University School of Medicine, Kobe, Japan.
Ophthalmology
|March 10, 2001
Summary
Diabetic patients exhibit ocular surface disease, including reduced tear function and goblet cell loss, linked to poor metabolic control and neuropathy. These issues in diabetes impact eye health significantly.
Area of Science:
- Ophthalmology
- Diabetology
- Cell Biology
Background:
- Diabetes mellitus is a systemic disease with known ocular complications.
- Ocular surface disorders are increasingly recognized in diabetic patients.
- Understanding these disorders is crucial for comprehensive diabetes care.
Purpose of the Study:
- To characterize the ocular surface disorder in patients with diabetes.
- To investigate the relationship between ocular surface changes and diabetic complications.
Main Methods:
- A prospective, case-controlled study involving 50 diabetic patients and 20 healthy controls.
- Ophthalmic examinations, corneal sensitivity, Schirmer test, tear film break-up time (BUT), and conjunctival impression cytology were performed.
- Analysis included comparisons of ocular surface parameters and their correlation with diabetic peripheral neuropathy, metabolic control, disease duration, and retinopathy status.
Main Results:
- Diabetic patients showed significantly lower corneal sensitivity, BUT, and Schirmer test values compared to controls.
- Conjunctival impression cytology revealed goblet cell loss and squamous metaplasia in diabetic patients.
- These ocular surface changes correlated with peripheral neuropathy, poor metabolic control, and reduced corneal sensitivity, but not with disease duration or retinopathy status.
Conclusions:
- Diabetic ocular surface disease is characterized by impaired tear quantity and quality, goblet cell loss, and squamous metaplasia.
- These findings are closely associated with the patient's metabolic control status and the presence of peripheral neuropathy.
- Management of metabolic control and neuropathy may be key in addressing ocular surface issues in diabetes.